SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-036671
Filing Date
2019-06-20
Accepted
2019-06-20 16:01:21
Documents
3
Period of Report
2019-06-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-11620_38k.htm 8-K 69936
2 EX-10.1 a19-11620_3ex10d1.htm EX-10.1 121175
3 EX-10.2 a19-11620_3ex10d2.htm EX-10.2 30233
  Complete submission text file 0001104659-19-036671.txt   222858
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 19908571
SIC: 2835 In Vitro & In Vivo Diagnostic Substances